This guide explains how FDA import detentions work for businesses in Countyline Corporate Park — the rules, the deadlines, the process and the mistakes — and how Garg Law handles them. Countyline Corporate Park, rising along the Medley–Hialeah Gardens boundary, is Miami-Dade’s newest large-scale industrial campus — modern big-box distribution space filling with grocery, consumer-product and cold-storage operations. New facilities mean new import programs, and new import programs are exactly where FDA entry review, FSVP verification and CBP targeting tend to find their first problems.
Quick answer
When FDA detains a shipment, the agency has decided the goods appear to violate the Food, Drug, and Cosmetic Act — and you have a short window to respond with evidence before the detention hardens into a refusal of admission. A focused, well-documented response filed quickly is usually the difference between release and losing the shipment.
1. Overview: the regulatory framework
FDA screens every import line of food, drugs, cosmetics, dietary supplements and medical devices filed through U.S. ports. When an entry is flagged, FDA issues a Notice of FDA Action stating that the article “appears” to violate the Food, Drug, and Cosmetic Act — under section 801(a), an appearance of a violation is all the agency needs. The notice sets a deadline to submit testimony: evidence that the goods comply, or a plan to bring them into compliance.
Detentions arise from labeling defects, suspected unapproved drug claims, missing registrations or listings, filth or contamination findings, an import-alert match, or simply an entry filed with the wrong product code. Each cause calls for a different response — private laboratory analysis, corrected labeling under a reconditioning plan (FDA Form 766), registration fixes, or documentary proof that the alert does not apply to your product.
Miss the deadline or file a weak response and FDA issues a refusal of admission. Refused goods must be exported or destroyed, generally within 90 days, and a refusal on your record raises your risk profile for every future entry.
2. What is at stake
A detained container accrues storage, demurrage and detention charges daily while the goods sit; perishable and seasonal merchandise can lose its entire value before a slow response is even read. Repeated refusals can also land a firm or product on an import alert, converting a one-shipment problem into automatic detention of everything you ship.
3. Step-by-step: how the matter proceeds
- Same-day review of the Notice of FDA Action, the entry documents and the charge codes to identify exactly why FDA acted
- Evidence strategy — private lab testing, affidavits, labeling corrections or supplier documentation matched to the specific charge
- Preparation and submission of testimony to the FDA district’s import operations branch before the response deadline
- Where compliance is achievable, a reconditioning proposal on FDA Form 766 with a realistic plan FDA will accept
- Follow-through with FDA compliance officers until the shipment is released — and root-cause fixes so the next entry clears
4. Common errors to avoid
- Waiting to see whether the shipment “clears on its own” while the testimony deadline runs
- Sending FDA a protest letter instead of evidence keyed to the specific charge
- Using an unaccredited lab or sampling the wrong lots, making the results unusable
- Letting the customs broker improvise a regulatory response outside their expertise
- Exporting the goods without addressing the cause, guaranteeing the next detention
Countyline Corporate Park: the local picture
The work around Countyline Corporate Park — regional distribution centers, food and grocery logistics, consumer products importers, cold storage, meat and produce distribution — is FDA-regulated at nearly every turn, and matters here move on the Medley–Hialeah Gardens line off the Turnpike’s Okeechobee interchange, in Miami-Dade’s newest big-box industrial corridor. Garg Law's Miami office is at 1221 Brickell Avenue, and the practice was built for exactly this market: founder Shelly Garg spent years counseling importers at the world's largest dedicated international trade law firm before opening her own, and works at the crossroads of FDA and CBP compliance for foreign and domestic companies across the food, beverage, supplement, cosmetics, OTC drug and medical device industries.
Frequently asked questions
How long do I have to respond to an FDA detention notice?
The Notice of FDA Action states your deadline — commonly around ten business days to submit testimony, though extensions can be requested. The practical answer is: respond as fast as a complete, evidence-backed submission can be assembled, because storage charges and product shelf life do not wait.
Can a detained shipment be released without testing?
Sometimes. If the charge is documentary — a registration, listing or labeling issue — corrected documents or a reconditioning plan may resolve it without laboratory work. Where FDA alleges contamination or adulteration, private analysis from an accredited laboratory is usually the core of the response.
What happens if FDA refuses my shipment?
Refused merchandise must be exported or destroyed under CBP supervision, generally within 90 days. The refusal also becomes part of your import history, increasing future screening — which is why fighting the detention properly the first time matters.
Does FDA detention mean my goods were physically inspected?
Not necessarily. Many detentions are “without physical examination” — triggered by an import alert or electronic screening rather than an exam. Your response strategy differs sharply depending on which kind you face.
Should my customs broker handle the FDA response?
Brokers are essential for entry filing, but an FDA detention is a regulatory legal proceeding: the response is evidence and argument to a federal agency about the Food, Drug, and Cosmetic Act. That is attorney work, done in coordination with your broker.